Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × liposomal doxorubicin × Clear all

NCT06023862 2025-06-15

DOVE

Phase 2 Recruiting

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT00401635 2007-09-05

END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin

Phase 2 Completed

Recurrence, Endometrial Neoplasms